UCB - Umsatzerlöse





Der Umsatz Veränderung Datum
Alcon AG USD 2.69B 10M 2026-03
Almirall EUR 602.71M 55.09M 2026-06
Amarin USD 49.22M 451K 2025-12
argenx SE USD 1.36B 240M 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Bayer EUR 13.41B 1.97B 2026-03
Genmab DKK 1.06B 36M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
GRIFOLS EUR 1.87B 170M 2026-06
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lakefront Biotherapeutics EUR 6.5M 894.32M 2026-03
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.13B 120M 2026-03
Novartis USD 14.41B 1.3B 2026-06
Orion EUR 521.6M 103.9M 2026-06
Recordati EUR 681.35M 32.07M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 11.24B 60M 2026-03
UCB EUR 4.25B 764M 2025-12
Unibail Rodamco EUR 1.49B 77M 2025-12